Skip to main content

Dupont Jakob's Form 4 filing

Pyxis Oncology, Inc. (PYXS) · filed Jul 2, 2026

Accession no.
0001193125-26-294708
Filed
Jul 2, 2026, 4:30 PM ET
Trade date
Jun 30, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $107.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dupont JakobCIK 0001553335Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 30, 2026Common StockMOption exerciseAcquired+35,000$1.60+$56,00073,741Direct
Jun 30, 2026Common StockSSaleDisposed−35,000$3.06F2,F3−$107,10038,741Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 30, 2026Common StockMOption exerciseDisposed−35,000$0.00$0357,461Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 of this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The transaction was executed in multiple trades in prices ranging from $3.00 to $3.36.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)